Measures IgA and IgG antibodies against deamidated gliadin peptides (DGP) and tissue transglutaminase (tTG), which may be elevated in coeliac disease.
Used to support the evaluation of suspected coeliac disease in people with compatible symptoms or increased risk. Results should be interpreted with clinical findings and may require confirmation with an intestinal biopsy.